Novel genetically encoded contrast agents for preclinical optoacoustic imaging
Dr André Stiel, group leader at the Institute of Biological Medical Imaging at the Helmholtz Zentrum in Munich
Imaging skin inflammation by means of Raster-Scanning Optoacoustic Mesoscopy (RSOM)
Dr. Juan Aguirre, PhD, Group Leader at the Institute for Biological and Medical Imaging at the Helmholtz Zentrum Munich and at the Chair of Biological Imaging of the Technical University of Munich
Imaging Lymphatic Disorders with Optoacoustic Tomography
Guido Giacalone, M.D., Ph.D., Lymphatic Surgery in Mechelen, Belgium.
Multi-scale Clinical Optoacoustic Skin Imaging
Dr. Dinish U S, Group Leader, A*STAR Singapore Bioimaging Consortium (SBIC)
Dr. Chris Ho, Business Development Manager, A*STAR Singapore Bioimaging Consortium (SBIC)
Optoacoustic Imaging in Neuromuscular Disease
Dr. med. Ferdinand Knieling, University Hospital Erlangen Pediatrician
Optoacoustics and Optical: Complementary Modalities for Molecular Imaging
Judith Weber PhD, University of Cambridge
Alexa Hasenbach, University of Münster
Dr. Sheryl Roberts, Memorial Sloan Kettering
Clinical Vascular Imaging with Multispectral Optoacoustic Tomography (MSOT)
Dr. Max Masthoff MD, PhD, University Hospital Munster, Germany
MSOT and MRI – Complementary Modalities for Pre-clinical Imaging
Dr. Mark ‘Marty’ Pagel, Department of Cancer Systems Imaging, MD Anderson Cancer Center
Innovations in Optoacoustic Imaging for Preclinical and Clinical Research
Neal Burton, PhD, Team Lead Applications, iThera Medical
Imaging Tumor Function and Response with Optoacoustics
Dr. Katja Haedicke, iThera Medical